Insider Trading History of Litvack Frank

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Litvack Frank since 2006. This trader's CIK number is 1310715. At the time of last reporting, Litvack Frank was the Officer of Capricor Therapeutics, Inc.. (stock ticker symbol CAPR). Also see all insider trading activities at Capricor Therapeutics, Inc..

Note that in the past Litvack Frank also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Conor Medsystems Inc (CONR) by Litvack Frank

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2006 CONR 0 $0 106,260 $2,918,654 0 $0

Yearly summary of insider trading at Capricor Therapeutics, Inc. (CAPR) by Litvack Frank

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 CAPR 0 $0 0 $0 25,000 $34,750
2024 CAPR 0 $0 0 $0 20,391 $22,430
2023 CAPR 0 $0 0 $0 34,775 $48,336
2022 CAPR 0 $0 0 $0 154,543 $214,814


Insider trading activities at 2 companies by Litvack Frank:

1. Conor Medsystems Inc (CONR)

2. Capricor Therapeutics, Inc. (CAPR)

Table 1. Insider trading of Conor Medsystems Inc (CONR) by Litvack Frank

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2006-12-15 CONR Sale 31,260 31.69 990,629
2006-02-27 CONR Sale 75,000 25.71 1,928,025

Table 2. Insider trading of Capricor Therapeutics, Inc. (CAPR) by Litvack Frank

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-03 CAPR Option Ex 25,000 1.39 34,750
2024-12-03 CAPR Option Ex 20,391 1.10 22,430
2023-08-14 CAPR Option Ex 20,748 1.39 28,839
2023-02-21 CAPR Option Ex 14,027 1.39 19,497
2022-01-03 CAPR Option Ex 154,543 1.39 214,814

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Litvack Frank (Officer of Capricor Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.